1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Veriseti
Veriseti
Kaynak
:
Yazar(lar) :
Yıl :
2020
Fr-SARS-CoV-2 Tentative de classement du nombre de cas confirmés du virus
SARS-
CoV-
2 sur le territoire français par régions.Les données sont issues des médias et /article/points-de-situation-
coronavirus-
covid-
19- https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-
coronavirus /articles/infection-au-nouveau-
coronavirus-
sars-
cov-
2-
covid-
19-france-et-monde- https://france3-regions.francetvinfo.fr- https://www.ars.sante.fr/- https sars cov 2 coronavirus covid 19
2
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
New Coronavirus COVID-19 (SARS-CoV-2) covid-19 (sars-cov-2)
3
Araştırma Makalesi
Araştırma Makalesi
Kaynak
:
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 neutralizing antibody development strategies Owing to a high rate of transmission from human to human, the new virus called
SARS-
CoV-
2 differed from others by its unexpectedly rapid spread. No approved targeted-therapies are available for
COVID-
19, yet. This review aims to provide some of the neutralizing antibody development strategies for
SARS-
CoV-
2 and in vitro and in vivo neutralization assays.
4
e-Kitap
e-Kitap
Kaynak
:
Dergi:
Yayıncı:
Internet Archive
Yazar(lar) :
Yıl :
2020
Studies Investigating Potential Inhibitors of Novel Coronavirus (SARS-CoV-2) COVID-19 Emergence of
COVID-
19 in China in late 2019 has now lead to a global pandemic.
5
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Wei E. Huang
,
Boon Lim
,
Chiau2010Chen Hsu
,
Dan Xiong
,
Wei Wu
,
Yejiong Yu
,
Huidong Jia
,
Yun Wang
,
Yida Zeng
,
Mengmeng Ji
,
Hong Chang
,
Xiuming Zhang
,
Hui Wang
,
Zhanfeng Cui
Yıl :
2020
RT‐LAMP for rapid diagnosis of coronavirus SARS‐CoV‐2 Summary The pandemic
coronavirus
SARS‐
CoV‐
2 in the world has caused a large infected population suffering from
COVID‐
19. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of
SARS‐
CoV‐
2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of
SARS‐
CoV‐
2 in the regions of orf1ab, S gene and N gene.
6
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Novel Coronavirus (SARS-CoV-2) Pandemic: Overview and Current Status The disease was later named as
COVID-
19 (
coronavirus disease 2019) and the causative agent was designated as
SARS-
CoV-
2 (severe acute respiratory syndrome coronavirus
2). The knowledge on the characteristics and epidemiology of
SARS-
CoV-
2 and
COVID-
19 has been increasing day by day. severe acute respiratory syndrome coronavirus 2 sars-cov-2 covid-19
7
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Epidemiology of SARS-CoV-2: numbers matter! The ongoing pandemic is the result of the spread of a recently identified
Coronavirus, named
SARS-
CoV-
2 (Severe Acute Respiratory Syndrome –
Coronavirus –
2). Since 31th December 2019, when the first cluster was reported in Wuhan (China), the global Novel
COronaVIrus Disease 2019 (
COVID-
19) cases significantly covid-19 sars-cov-2 coronavirus
8
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Assessing Immune Response to SARS-CoV-2 Infection In 2002, the first known case of severe acute respiratory syndrome (
SARS) occurred in China and
SARS
coronavirus (
SARS-
CoV) was identified in 2003.1 Before The World Health Organization (WHO) on March 11, 2020, declared
coronavirus disease 2019 (
COVID-
19) caused by severe acute respiratory syndrome
coronavirus 2 (
SARS-
CoV-
2) a pandemic. sars-cov-2 covid-19 coronavirus
9
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health SARS-CoV-2 COVID-19
10
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Marcos F. DosSantos
,
Marcos F. DosSantos
,
Marcos F. DosSantos
,
Sylvie Devalle
,
Veronica Aran
,
Daniela Capra
,
Daniela Capra
,
Daniela Capra
,
Natália Roberta Roque
,
Juliana de Mattos Coelho-Aguiar
,
Tânia Cristina Leite de Sampaio e Spohr
,
Tânia Cristina Leite de Sampaio e Spohr
,
Janice Gonçalves Subilhaga
,
Cláudia Maria Pereira
,
Isabella D'Andrea Meira
,
Isabella D'Andrea Meira
,
Isabella D'Andrea Meira
,
Paulo Niemeyer Soares Filho
,
Vivaldo Moura-Neto
,
Vivaldo Moura-Neto
,
Vivaldo Moura-Neto
,
Vivaldo Moura-Neto
,
Vivaldo Moura-Neto
Yıl :
2020
Neuromechanisms of SARS-CoV-2: A Review Recent studies have suggested the neuroinvasive potential of severe acute respiratory
coronavirus
2 (
SARS-
CoV-
2). Notably, neuroinvasiveness might be involved in the pathophysiology of
coronavirus disease 2019 (
COVID-
19). Here, we review the current literature that indicates that
SARS-
CoV-
2 can invade the nervous system. SARS-CoV-2 COVID-19
11
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Coronavirus-SARS-CoV-2: Biology and Problems in rRT-PCR Detection Coronavirus disease 2019 (
COVID-
19) first appeared in China in December 2019 and was declared a pandemic by the World Health Organization. COVID-
19 is caused by Severe Acute Respiratory Syndrome Corona Virus
2 (
SARS-
CoV-
2), a new virus previously unknown to humans. covid-19 sars-cov-2
12
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Meningoencephalitis from SARS-CoV-2 infection The current global pandemic of
COVID-
19 disease is caused by a novel
coronavirus
SARS-
CoV-
2. We report a case of a 35-year-old woman with meningoencephalitis associated with
COVID-
19 disease who presented with altered mental status and rhythmic Although rare, meningoencephalitis should be considered as a possible manifestation of
COVID-
19 disease. COVID-19 SARS-CoV-2 Coronavirus
13
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Is SARS-CoV-2 Vertically Transmitted? At the end of 2019, in Wuhan (China), the onset of a disease caused by severe acute respiratory syndrome
coronavirus
2 (
SARS-
CoV-
2) was observed. ,” “
COVID-
19,” and “vertical transmission.” Few studies about the vertical transmission of
SARS-
CoV-
2 are found in the literature. SARS-CoV-2 COVID-19
14
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 The recent outbreak of the
Coronavirus disease 2019 (
COVID-
19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. -
19. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of
COVID-
19. COVID-19 SARS-CoV-2
15
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy (
SARS-
CoV-
2) in all its regions. While such efforts are still ongoing, uncertainties regarding
SARS-
CoV-
2 transmissibility and ascertainment of cases make it difficult to evaluate the Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported
SARS-
CoV-
2 cases (18.4%; 95%CI = 0–34.0%) before 10 novel coronavirus COVID-19
16
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
The SARS-CoV-2 outbreak: What we know There is a current worldwide outbreak of the novel
coronavirus
Covid-
19 (
coronavirus disease 2019; the pathogen called
SARS-
CoV-
2; previously 2019-nCoV ), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March
2, 2020. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of
coronavirus Coronavirus SARS-CoV-2 CoVID-19
17
Dergi Makalesi
Dergi Makalesi
Kaynak
:
Yayıncı:
ORA - Oxford University Research Archive
Yazar(lar) :
Yıl :
2020
RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 The pandemic
coronavirus
SARS‐
CoV‐
2 in the world has caused a large infected population suffering from
COVID‐
19. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of
SARS‐
CoV‐
2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of
SARS‐
CoV‐
2 in the regions of orf1ab, S gene and N gene. sars-cov-2 virus covid-19
18
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Guillain-Barré syndrome and SARS-CoV-2 Abstract Since January 2020, after Chinese health authorities identified a new type of
coronavirus (
SARS-
CoV-
2), the virus has spread throughout China This article presents the case of a 65-years old man who was presumptively infected with
SARS-
CoV-
2 during his ski vacation in Austria in March 2020 and COVID-19 SARS-CoV-2
19
Dergi Makalesi
Dergi Makalesi
Dergi:
Yıl :
2020
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus COVID-19 Sars-CoV-2 coronavirus
20
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units The current outbreak of
SARS-
CoV-
2 represents a special risk for renal patients due to their comorbidities and advanced age. particular in hemodialysis units, with the objective of early identification of patients who meet the definition of a suspected case of infection by
SARS-
CoV Resumen: La epidemia de
SARS-
CoV-
2 representa un riesgo especial para los pacientes renales por su condición de personas con comorbilidades y edad avanzada SARS-CoV-2 COVID-19 Coronavirus
21
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2 En diciembre de 2019 surgió en China un nuevo
coronavirus, conocido como
SARS-
CoV-
2 y causante de la enfermedad
COVID-
19. SARS-
CoV que apareció a comienzo de este siglo en China y el MERS-
CoV que surgió en Arabia en 2012. SARS-
CoV-
2 empezó a propagarse en un mercado de la ciudad de Wuhan (China) donde se vendían pescados, mariscos y diferentes animales vivos. sars-cov-2 novel coronavirus covid-19
22
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far They were caused by a previously unknown
coronavirus. Based on clinical criteria and available serological and molecular information, the new disease was called
coronavirus disease of 2019 (
COVID-
19), and the novel
coronavirus was called
SARS
Coronavirus-
2 (
SARS-
CoV-
2), emphasizing its close relationship to the 2002
SARS virus (
SARS-
CoV). coronavirus covid-19 sars-cov-2
23
Dergi Makalesi
Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Bezmialem Vakıf Üniversitesi
Yazar(lar) :
Konu :
19
Yıl :
2020
SARS CoV-2 Pathogenesis and Immune Response The beginning of 2020 has seen the emergence of
COVID-
19, an outbreak caused by a novel
coronavirus,
SARS-
CoV-
2, an important pathogen for humans. In Iran, the first case of the
COVID-
19 was reported after spread from China and other countries. Laboratory evidence of clinical patients showed that a specific T-cell response against
SARS-
CoV-
2 is important for the recognition and killing of infected 19 19
24
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany During a meeting in Munich, Germany, a presymptomatic attendee with severe acute respiratory syndrome
coronavirus
2 infected at least 11 of 13 other participants Although 5 participants had no or mild symptoms, 6 had typical
coronavirus disease, without dyspnea. COVID-19 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
25
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 Persistence: Data Summary up to Q2 2020 The
coronavirus pandemic is causing confusion in the world. This confusion also affects the different guidelines adopted by each country. The persistence of
Coronavirus, responsible for
coronavirus disease 2019 (
Covid-
19) has been evaluated by different articles, but it is still not well-defined The aim of this manuscript is to underline new
Coronavirus persistence features on different environments and surfaces. COVID-19
26
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge COVID-19
27
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
COVID-19: the novel SARS-CoV-2 pandemic During the first weeks of 2020, cases of
SARS-
CoV-
2 began to be reported outside of China, with a rapid increase in cases and deaths worldwide. SARS-
CoV-
2 is a positive single-stranded RNA virus, encased in a lipid bilayer derived from the host cell membrane and consists of four structural proteins are no large-scale studies regarding the use of chloroquine / hydroxychloroquine, due to the global situation, its use has been authorized for its anti-
SARS-
CoV infecciones por coronavirus
28
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Disinfection measures and control of SARS-COV-2 transmission A new virus, classified as a variant of the
coronavirus that causes severe acute respiratory syndrome (
SARS), is severe acute respiratory syndrome
coronavirus 2 or
SARS-
CoV-
2. covid-19 coronavirus
29
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak of 5,204,508 confirmed cases, with 212 countries being affected by the novel
coronavirus. 2019 novel
coronavirus (
SARS-
CoV-
2) is that the seventh member The
SARS-
CoV-
2 may be a β-
CoV of group 2B there is 70% comparability in genetic sequence to
SARS-
CoV. With whole-genome sequences of
SARS-
CoV-
2 is 96% comparatively at the whole-genome level to a bat
coronavirus. covid-19 coronavirus sars-cov